Comments Submitted to the FDA Regarding the Reauthorization of the Prescription Drug User Fee Act
In comments submitted to the Food and Drug Administration (FDA), Public Citizen provided specific suggestions to modify the agency’s draft Commitment Letter regarding reauthorization of the Prescription Drug User Fee Act in order to enhance the public health and regulatory focus of the FDA’s drug and biologic review and oversight programs.
See Public Citizen’s other work regarding the drug approval process.